Aziyo Biologics, Inc. (AZYO) Tops Q1 EPS by 8c

Aziyo Biologics, Inc. (NASDAQ: AZYO) reported Q1 EPS of ($0.49), $0.08 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $13.7 million.

For earnings history and earnings-related data on Aziyo Biologics, Inc. (AZYO) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
• BofA maintains underperform ratings on six BDC stocks